Breaking News

Saphetor, ICON Partner to Develop Precision Medicine Clinical Trial Strategies

Companies working towards improving the power and cost-effectiveness of clinical trial planning and execution.

Saphetor SA, is partnering with ICON to develop an innovative approach to support the planning and execution of clinical trials in the precision medicine and rare diseases space. The companies are exploring how Saphetor’s variant interpretation platform VarSome.com can be further leveraged in terms of the epidemiology, prevalence, and location trends of genetic mutations, thereby supporting patient recruitment and overall clinical trial strategy. ICON provides outsourced services to pharmaceu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters